IMPACTASSETS 50™
An Annual Showcase of Impact Investment Fund Managers
ImpactAssets 50
An Annual Showcase of Impact Investment Fund Managers
Coyote Ventures
Gender Equality
Health and Wellbeing
Racial Equity and JusticeFirm Overview
Coyote Ventures backs founders who are solving problems that disproportionately affect overlooked populations, with a foundation in women’s health. Founded by scientists, entrepreneurs, and investors, Coyote takes an integrative view of health that spans physical, financial, and emotional health. General Partner Jessica Karr was a Biochemist at Impossible Foods and has hands-on experience building and launching novel products. The Coyote team includes 12 Venture Partners and over 50 expert advisors.
Years of Operation: 3 – 4 years
% of Capital from Top 3 Investors: Less than 25%
Coyote Ventures backs founders who are solving problems that disproportionately affect overlooked populations, with a foundation in women’s health.
Coyote Ventures backs founders who are solving problems that disproportionately affect overlooked populations, with a foundation in women’s health. Founded by scientists, entrepreneurs, and investors, Coyote takes an integrative view of health that spans physical, financial, and emotional health. General Partner Jessica Karr was a Biochemist at Impossible Foods and has hands-on experience building and launching novel products. The Coyote team includes 12 Venture Partners and over 50 expert advisors. Coyote has completed 12 investments, and is actively investing to create a synergistic portfolio of innovative health-centric solutions.
There are few venture capital funds focused on improving women’s lives. Coyote Ventures is focused on health and wellness with a lens on how innovations improve sustainable development goals of gender equality, good health and wellbeing, and responsible production and consumption. General Partner Jessica Karr was a biochemist, early employee at Impossible Foods, and has a vast experience working with startups and investors. Our all-female deal team is community driven, and our expert advisory network includes medical doctors, scientists, and health tech executives. Our focus on diligence and portfolio support with a medical and science emphasis is a core differentiator.
Investment Example
Coyote Ventures invested in Malama Health's Seed round. Malama Health aims to improve maternal and childbirth outcomes related to high risk pregnancies. Malama's first product replaces an archaic pen and paper system for pregnant people diagnosed with gestational diabetes, a condition that affects nearly 1 in 5 pregnancies. Their HIPAA-compliant remote monitoring makes it easy for patients and providers to track glucose and meal data. Gestational diabetes can have significant impacts on maternal and birth outcomes, including higher rates of cesarean births and premature births. Despite gestational diabetes’ widespread impact on the lives of pregnant women both in the U.S and globally, there are extremely limited ways that patients and providers can easily track and understand the disease. Malama Health now has launched several Medicaid Managed Plans to address birth equity.
Leadership and Team
 |
Jessica Karr – General Partner More Info
Jessica Karr is the Founder & General Partner of Coyote Ventures, an early stage venture capital fund investing in women’s health and wellness. Jessica’s experience launching novel impact-focused products began when she joined Impossible Foods as the 12th employee, where she helped develop and launch the Impossible burger. She has since worked with startups internationally as an innovation consultant and as a Principal with a family office. She is an LP in women-led funds and her angel investments have all become unicorns. Jessica lives in the Bay Area with her rescue Pom and enjoys swimming in the bay. |
 |
Maria Wang-Faulkner – Investment Committee Advisor More Info
Maria Wang-Faulkner is a business and product leader with 15+ years experience spanning go-to-market, product, strategy consulting and law. At Adobe, she is forging first-of-its-kind product partnerships to both distribute and supercharge Adobe's generative AI capabilities. Previously, she was Founding Product Manager at Freemodel, a Series A marketplace start-up. Before that, she was the Founder & CEO of Simone (formerly Fig Health), a venture-backed healthtech company for people with ovaries living with under-researched chronic conditions. Simone's flagship digital health product was ranked #1 in its category on both Apple and Google. |
 |
Jess Guenzl – Investment Committee Advisor More Info
Investing in female health startups at the earliest stages. Passionate about chronic pain (migraine awareness), mental health, sexual health education, sexual violence victim advocacy, and intimate (female, male, sexual, relationship, and family) health. |
Financial Performance
Impact Performance
|
Percentage of Total Assets Under
Management that are Impact Investments: |
100%
|
Coyote Ventures is investing in products and services that improve women's lives, our diligence process reviews the impact on gender equality as well as accessibility of pricing, geographic reach, design with racial equality in mind, and ways the products intersect with sustainability. One example, the first breast cancer risk assessment to include crucial racial data (former assessments were trained with heavily caucasian-focused data sets). Another example, a period product that decreases total number of tampons and pads to reach the landfill. We produce an annual impact report.
We only consider investments with female executives. 100% of our portfolio company CEO's are female. Many of the CEO's and co-founders are LGBTQ+, BIPOC, and living in diverse geographies.
Impact Tracking and Monitoring
Learn More
2261 Market Street #5549, San Francisco, CA 94114 USA
Apply for the IA 50 2022
The application period to become an ImpactAssets 50 2022 Fund Manager will open in September 2021!
To stay informed on the application process, sign up here.